BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg. 1995;169:36-42; discussion 42-43. [PMID: 7817996 DOI: 10.1016/s0002-9610(99)80107-x] [Cited by in Crossref: 313] [Cited by in F6Publishing: 65] [Article Influence: 11.6] [Reference Citation Analysis]
Number Citing Articles
1 Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, Hawkins R, McNicol AM, Reed N, Sutton R. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut. 2005;54 Suppl 4:iv1-i16. [PMID: 15888809 DOI: 10.1136/gut.2004.053314] [Cited by in Crossref: 173] [Cited by in F6Publishing: 192] [Article Influence: 10.2] [Reference Citation Analysis]
2 Heinrich S, Watzka F, Lang H. Integrative Concepts for Liver Surgery. Visc Med 2020;36:351-8. [PMID: 33178731 DOI: 10.1159/000511043] [Reference Citation Analysis]
3 Maekawa A, Kudo A, Kishino M, Murase Y, Watanabe S, Ishikawa Y, Ueda H, Akahoshi K, Ogawa K, Ono H, Tanaka S, Kinowaki Y, Tanabe M. Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy. J Cancer Res Clin Oncol 2021. [PMID: 33904982 DOI: 10.1007/s00432-021-03650-2] [Reference Citation Analysis]
4 Maxwell JE, Sherman SK, O'Dorisio TM, Bellizzi AM, Howe JR. Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy? Surgery. 2016;159:320-333. [PMID: 26454679 DOI: 10.1016/j.surg.2015.05.040] [Cited by in Crossref: 86] [Cited by in F6Publishing: 69] [Article Influence: 12.3] [Reference Citation Analysis]
5 Abou El Fadil-Nicol F, Berger F, Descroix-Vagne M, Pansu D. Presence of sorbin in human digestive tract and endocrine digestive tumours. Gut 2000;46:182-90. [PMID: 10644311 DOI: 10.1136/gut.46.2.182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Tran CG, Sherman SK, Howe JR. Small Bowel Neuroendocrine Tumors. Curr Probl Surg 2020;57:100823. [PMID: 33234227 DOI: 10.1016/j.cpsurg.2020.100823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nadler A, Cukier M, Milot L, Singh S, Law CH. Hepatic parenchymal preserving technique in the management of diffuse bilateral neuroendocrine tumour liver metastases: a feasible approach. Can J Surg 2014;57:E2-8. [PMID: 24666455 DOI: 10.1503/cjs.014112] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Loughrey PB, Zhang D, Heaney AP. New Treatments for the Carcinoid Syndrome. Endocrinol Metab Clin North Am 2018;47:557-76. [PMID: 30098716 DOI: 10.1016/j.ecl.2018.04.014] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Raut CP, Kulke MH, Glickman JN, Swanson RS, Ashley SW. Carcinoid Tumors. Current Problems in Surgery 2006;43:391-450. [DOI: 10.1067/j.cpsurg.2006.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Castaldo ET, Pinson CW. Liver transplantation for non-hepatocellular carcinoma malignancy. HPB (Oxford) 2007;9:98-103. [PMID: 18333123 DOI: 10.1080/13651820601156090] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
11 Gaujoux S, Sauvanet A, Belghiti J. Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors. Target Oncol 2012;7:153-9. [PMID: 22923166 DOI: 10.1007/s11523-012-0230-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Gomez D, Malik HZ, Al-Mukthar A, Menon KV, Toogood GJ, Lodge JP, Prasad KR. Hepatic resection for metastatic gastrointestinal and pancreatic neuroendocrine tumours: outcome and prognostic predictors. HPB (Oxford) 2007;9:345-51. [PMID: 18345317 DOI: 10.1080/13651820701504199] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
13 Gu P, Wu J, Newman E, Muggia F. Treatment of liver metastases in patients with neuroendocrine tumors of gastroesophageal and pancreatic origin. Int J Hepatol 2012;2012:131659. [PMID: 22518318 DOI: 10.1155/2012/131659] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
14 Chan MY, Ma KW, Chan A. Surgical management of neuroendocrine tumor-associated liver metastases: a review. Gland Surg 2018;7:28-35. [PMID: 29629317 DOI: 10.21037/gs.2017.11.16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
15 Kulke MH. New developments in the treatment of gastrointestinal neuroendocrine tumors. Curr Oncol Rep. 2007;9:177-183. [PMID: 17430688 DOI: 10.1007/s11912-007-0019-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
16 House MG, Cameron JL, Lillemoe KD, Schulick RD, Choti MA, Hansel DE, Hruban RH, Maitra A, Yeo CJ. Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer. J Gastrointest Surg. 2006;10:138-145. [PMID: 16368504 DOI: 10.1016/j.gassur.2005.05.004] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
17 Chung TP, Hunt SR. Carcinoid and neuroendocrine tumors of the colon and rectum. Clin Colon Rectal Surg 2006;19:45-8. [PMID: 20011309 DOI: 10.1055/s-2006-942343] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
18 Fabian E, Haas B, Kump P, Lipp R, Kornprat P, Lutfi A, Talakic E, Fuchsjäger M, Spindelboeck W, Lackner C, Zollner G, Krejs GJ. Clinical-Pathological Conference Series from the Medical University of Graz : Case No 154: 32-year-old computer software engineer with nodular mass in the liver. Wien Klin Wochenschr 2016;128:277-86. [PMID: 26919853 DOI: 10.1007/s00508-016-0965-1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, Law CH, Liu EH, Kim MK, Menda Y, Morse BG, Bergsland EK, Strosberg JR, Nakakura EK, Pommier RF. The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society. Pancreas. 2017;46:715-731. [PMID: 28609357 DOI: 10.1097/mpa.0000000000000846] [Cited by in Crossref: 127] [Cited by in F6Publishing: 57] [Article Influence: 31.8] [Reference Citation Analysis]
20 Touzios JG, Kiely JM, Pitt SC, Rilling WS, Quebbeman EJ, Wilson SD, Pitt HA. Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg. 2005;241:776-783; discussion 783-785. [PMID: 15849513 DOI: 10.1097/01.sla.0000161981.58631.ab] [Cited by in Crossref: 250] [Cited by in F6Publishing: 213] [Article Influence: 14.7] [Reference Citation Analysis]
21 Fendrich V, Bartsch DK. Surgical treatment of gastrointestinal neuroendocrine tumors. Langenbecks Arch Surg. 2011;396:299-311. [PMID: 21279821 DOI: 10.1007/s00423-011-0741-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
22 Raut CP, Lee JE. Unusual functioning endocrine tumors. Curr Treat Options Oncol 2004;5:327-34. [PMID: 15233909 DOI: 10.1007/s11864-004-0023-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Lang H, Nussbaum KT, Kaudel P, Frühauf N, Flemming P, Raab R. Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period. Ann Surg. 2000;231:500-505. [PMID: 10749609 DOI: 10.1097/00000658-200004000-00007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Lang H, Oldhafer KJ, Weimann A, Schlitt HJ, Scheumann GF, Flemming P, Ringe B, Pichlmayr R. Liver transplantation for metastatic neuroendocrine tumors. Ann Surg. 1997;225:347-354. [PMID: 9114792 DOI: 10.1097/00000658-199704000-00002] [Cited by in Crossref: 108] [Cited by in F6Publishing: 84] [Article Influence: 4.3] [Reference Citation Analysis]
25 Buicko JL, Finnerty BM, Zhang T, Kim BJ, Fahey TJ, Nancy Du YC. Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors. Ann Pancreat Cancer. 2019;2. [PMID: 31535089 DOI: 10.21037/apc.2019.06.02] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
26 Patel D, Chan D, Cehic G, Pavlakis N, Price TJ. Systemic therapies for advanced gastroenteropancreatic neuroendocrine tumors. Expert Rev Endocrinol Metab 2016;11:311-27. [PMID: 30058926 DOI: 10.1080/17446651.2016.1199952] [Reference Citation Analysis]
27 Lee SY, Cheow PC, Teo JY, Ooi LL. Surgical treatment of neuroendocrine liver metastases. Int J Hepatol 2012;2012:146590. [PMID: 22319650 DOI: 10.1155/2012/146590] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
28 Alagusundaramoorthy SS, Gedaly R. Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor. World J Gastroenterol 2014; 20(39): 14348-14358 [PMID: 25339822 DOI: 10.3748/wjg.v20.i39.14348] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
29 Schmidt C, Bloomston M, Shah MH. Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapies. Oncogene 2011;30:1497-505. [PMID: 21132004 DOI: 10.1038/onc.2010.548] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
30 Kulke MH, Bendell J, Kvols L, Picus J, Pommier R, Yao J. Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors. J Hematol Oncol. 2011;4:29. [PMID: 21672194 DOI: 10.1186/1756-8722-4-29] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
31 Riechelmann RP, Pereira AA, Rego JF, Costa FP. Refractory carcinoid syndrome: A review of treatment options. Ther Adv Med Oncol. 2017;9:127-137. [PMID: 28203303 DOI: 10.1177/1758834016675803] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
32 Norton JA, Jensen RT. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg. 2004;240:757-773. [PMID: 15492556 DOI: 10.1097/01.sla.0000143252.02142.3e] [Cited by in Crossref: 166] [Cited by in F6Publishing: 140] [Article Influence: 9.2] [Reference Citation Analysis]
33 Basuroy R, Srirajaskanthan R, Ramage JK. A multimodal approach to the management of neuroendocrine tumour liver metastases. Int J Hepatol 2012;2012:819193. [PMID: 22518323 DOI: 10.1155/2012/819193] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
34 Palesty JA, Al-Kasspooles M, Gibbs JF. Patient selection for surgical management of primary and metastatic liver cancers: current perspectives. Semin Intervent Radiol 2006;23:13-20. [PMID: 21326716 DOI: 10.1055/s-2006-939837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Ferrel B, Franko J, Tee MC. Rare case of pancreatic neuroendocrine tumour presenting as paraneoplastic hypercalcaemia. BMJ Case Rep 2021;14:e240786. [PMID: 33858893 DOI: 10.1136/bcr-2020-240786] [Reference Citation Analysis]
36 Mayo SC, Herman JM, Cosgrove D, Bhagat N, Kamel I, Geschwind JF, Pawlik TM. Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies. J Am Coll Surg 2013;216:123-34. [PMID: 23063263 DOI: 10.1016/j.jamcollsurg.2012.08.027] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
37 Pitt SC, Knuth J, Keily JM, McDermott JC, Weber SM, Chen H, Rilling WS, Quebbeman EJ, Agarwal DM, Pitt HA. Hepatic neuroendocrine metastases: chemo- or bland embolization? J Gastrointest Surg. 2008;12:1951-1960. [PMID: 18709512 DOI: 10.1007/s11605-008-0640-6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 5.4] [Reference Citation Analysis]
38 Tran CG, Sherman SK, Chandrasekharan C, Howe JR. Surgical Management of Neuroendocrine Tumor Liver Metastases. Surg Oncol Clin N Am 2021;30:39-55. [PMID: 33220808 DOI: 10.1016/j.soc.2020.08.001] [Reference Citation Analysis]
39 Woodside KJ, Townsend CM, Mark Evers B. Current management of gastrointestinal carcinoid tumors. J Gastrointest Surg. 2004;8:742-756. [PMID: 15358337 DOI: 10.1016/j.gassur.2004.04.010] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
40 DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 2001;234:540-7; discussion 547-8. [PMID: 11573047 DOI: 10.1097/00000658-200110000-00013] [Cited by in Crossref: 179] [Cited by in F6Publishing: 133] [Article Influence: 8.5] [Reference Citation Analysis]
41 Lang H, Nussbaum KT, Kaudel P, Frühauf N, Flemming P, Raab R. Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period. Ann Surg. 2000;231:500-505. [PMID: 10749609 DOI: 10.1097/00000658-200004000-00007] [Cited by in Crossref: 100] [Cited by in F6Publishing: 74] [Article Influence: 4.5] [Reference Citation Analysis]
42 Blonski WC, Reddy KR, Shaked A, Siegelman E, Metz DC. Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature. World J Gastroenterol. 2005;11:7676-7683. [PMID: 16437698 DOI: 10.3748/wjg.v11.i48.7676] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
43 Taner T, Atwell TD, Zhang L, Oberg TN, Harmsen WS, Slettedahl SW, Kendrick ML, Nagorney DM, Que FG. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection. HPB (Oxford). 2013;15:190-195. [PMID: 23374359 DOI: 10.1111/j.1477-2574.2012.00528.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
44 Chen H, Pruitt A, Nicol TL, Gorgulu S, Choti MA. Complete hepatic resection of metastases from leiomyosarcoma prolongs survival. J Gastrointest Surg. 1998;2:151-155. [PMID: 9834411 DOI: 10.1016/s1091-255x(98)80006-1] [Cited by in Crossref: 66] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
45 Frilling A, Sotiropoulos GC, Li J, Kornasiewicz O, Plöckinger U. Multimodal management of neuroendocrine liver metastases. HPB (Oxford). 2010;12:361-379. [PMID: 20662787 DOI: 10.1111/j.1477-2574.2010.00175.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 8.5] [Reference Citation Analysis]
46 Fendrich V, Langer P, Celik I, Bartsch DK, Zielke A, Ramaswamy A, Rothmund M. An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg. 2006;244:845-851; discussion 852-853. [PMID: 17122609 DOI: 10.1097/01.sla.0000246951.21252.60] [Cited by in Crossref: 114] [Cited by in F6Publishing: 92] [Article Influence: 7.6] [Reference Citation Analysis]
47 Glazer ES, Tseng JF, Al-Refaie W, Solorzano CC, Liu P, Willborn KA, Abdalla EK, Vauthey JN, Curley SA. Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford). 2010;12:427-433. [PMID: 20662794 DOI: 10.1111/j.1477-2574.2010.00198.x] [Cited by in Crossref: 136] [Cited by in F6Publishing: 110] [Article Influence: 12.4] [Reference Citation Analysis]
48 Sporn E, Mancini GJ, Khajanchee Y, Wilson C, Hansen PD, Swanstrom LL, Thaler K. Multimodal cytoreduction for carcinoid liver metastases: analysis of a case series with highly advanced disease. Eur Surg 2008;40:72-6. [DOI: 10.1007/s10353-008-0395-z] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
49 Lewis MA, Hubbard J. Multimodal liver-directed management of neuroendocrine hepatic metastases. Int J Hepatol. 2011;2011:452343. [PMID: 22121491 DOI: 10.4061/2011/452343] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
50 Feuerecker B, Scheidhauer K, Schwaiger M, Mustafa M. Intra-arterial radiopeptide therapy of hepatic metastases of neuroendocrine tumors: a systematic review. Clin Transl Imaging 2017;5:89-99. [DOI: 10.1007/s40336-016-0220-9] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
51 Chung JC, Choi DW, Jo SH, Heo JS, Choi SH, Kim YI. Malignant nonfunctioning endocrine tumors of the pancreas: predictive factors for survival after surgical treatment. World J Surg 2007;31:579-85. [PMID: 17219270 DOI: 10.1007/s00268-006-0585-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
52 Eto K, Yoshida N, Iwagami S, Iwatsuki M, Baba H. Surgical treatment for gastrointestinal neuroendocrine tumors. Ann Gastroenterol Surg 2020;4:652-9. [PMID: 33319155 DOI: 10.1002/ags3.12396] [Reference Citation Analysis]
53 Lee E, Leon Pachter H, Sarpel U. Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors. Int J Hepatol. 2012;2012:471203. [PMID: 22319651 DOI: 10.1155/2012/471203] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
54 Meij V, Zuetenhorst JM, van Hillegersberg R, Kröger R, Prevoo W, van Coevorden F, Taal BG. Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation. World J Surg Oncol 2005;3:75. [PMID: 16293186 DOI: 10.1186/1477-7819-3-75] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
55 Connolly HM, Pellikka PA. Carcinoid heart disease. Curr Cardiol Rep 2006;8:96-101. [PMID: 16524535 DOI: 10.1007/s11886-006-0019-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
56 Lee RC, Kanhere H, Trochsler M, Broadbridge V, Maddern G, Price TJ. Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases? World J Gastrointest Oncol 2018; 10(8): 211-220 [PMID: 30147847 DOI: 10.4251/wjgo.v10.i8.211] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
57 Bacchetti S, Pasqual EM, Bertozzi S, Londero AP, Risaliti A. Curative versus palliative surgical resection of liver metastases in patients with neuroendocrine tumors: a meta-analysis of observational studies. Gland Surg. 2014;3:243-251. [PMID: 25493256 DOI: 10.3978/j.issn.2227-684x.2014.02.05] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
58 Nigri G, Petrucciani N, Debs T, Mangogna LM, Crovetto A, Moschetta G, Persechino R, Aurello P, Ramacciato G. Treatment options for PNET liver metastases: a systematic review. World J Surg Oncol. 2018;16:142. [PMID: 30007406 DOI: 10.1186/s12957-018-1446-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
59 Strosberg JR, Weber JM, Choi J, Campos TL, Valone TL, Han G, Schell MJ, Kvols LK. A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors. Ann Oncol. 2012;23:2335-2341. [PMID: 22317769 DOI: 10.1093/annonc/mdr614] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
60 Fendrich V, Michl P, Habbe N, Bartsch DK. Liver-specific therapies for metastases of neuroendocrine pancreatic tumors. World J Hepatol 2010; 2(10): 367-373 [PMID: 21160945 DOI: 10.4254/wjh.v2.i10.367] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
61 Tran CG, Sherman SK, Howe JR. The Landmark Series: Management of Small Bowel Neuroendocrine Tumors. Ann Surg Oncol 2021;28:2741-51. [PMID: 33452604 DOI: 10.1245/s10434-020-09566-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 2003;10:1059-1069. [PMID: 14597445 DOI: 10.1245/aso.2003.03.026] [Cited by in Crossref: 215] [Cited by in F6Publishing: 74] [Article Influence: 11.9] [Reference Citation Analysis]
63 Sabel MS, Diehl KM, Chang AE. Principles of Surgical Therapy in Oncology. In: Chang AE, Hayes DF, Pass HI, Stone RM, Ganz PA, Kinsella TJ, Schiller JH, Strecher VJ, editors. Oncology. New York: Springer; 2006. pp. 58-72. [DOI: 10.1007/0-387-31056-8_4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumors. Oncologist. 2008;13:1255-1269. [PMID: 19091780 DOI: 10.1634/theoncologist.2008-0207] [Cited by in Crossref: 140] [Cited by in F6Publishing: 111] [Article Influence: 10.0] [Reference Citation Analysis]
65 Chan WF, Lo CY, Lo CM, Fan ST. Laparoscopic resection of a pancreatic polypeptidoma with a solitary liver metastasis. Surg Endosc. 2004;18:554-556. [PMID: 15115015 DOI: 10.1007/s00464-003-4220-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
66 Lesurtel M, Nagorney DM, Mazzaferro V, Jensen RT, Poston GJ. When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations. HPB (Oxford). 2015;17:17-22. [PMID: 24636662 DOI: 10.1111/hpb.12225] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
67 Haugvik SP, Labori KJ, Edwin B, Mathisen Ø, Gladhaug IP. Surgical treatment of sporadic pancreatic neuroendocrine tumors: a state of the art review. ScientificWorldJournal. 2012;2012:357475. [PMID: 23304085 DOI: 10.1100/2012/357475] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
68 Johanson V, Tisell LE, Olbe L, Wängberg B, Nilsson O, Ahlman H. Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin. Br J Cancer. 1999;80:1259-1261. [PMID: 10376980 DOI: 10.1038/sj.bjc.6690494] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
69 Sener SF. Results of surgical resection for metastatic liver tumors. Cancer Treat Res 2001;109:207-17. [PMID: 11775437 DOI: 10.1007/978-1-4757-3371-6_11] [Reference Citation Analysis]
70 Gangi A, Howe JR. The Landmark Series: Neuroendocrine Tumor Liver Metastases. Ann Surg Oncol 2020;27:3270-80. [PMID: 32632880 DOI: 10.1245/s10434-020-08787-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
71 Wilson HM. Chronic subacute bowel obstruction caused by carcinoid tumour misdiagnosed as irritable bowel syndrome: a case report. Cases J 2009;2:78. [PMID: 19161610 DOI: 10.1186/1757-1626-2-78] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
72 Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, Corrie P, Davar J, Davies AH, Lewington V, Meyer T, Newell-Price J, Poston G, Reed N, Rockall A, Steward W, Thakker RV, Toubanakis C, Valle J, Verbeke C, Grossman AB;  UK and Ireland Neuroendocrine Tumour Society. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut. 2012;61:6-32. [PMID: 22052063 DOI: 10.1136/gutjnl-2011-300831] [Cited by in Crossref: 353] [Cited by in F6Publishing: 280] [Article Influence: 32.1] [Reference Citation Analysis]
73 Tsalis K, Vrakas G, Vradelis S, Dimoulas A, Pilavaki M, Papaemmanouil S, Micheli A, Lazarides C, Kartalis G. Primary hepatic gastrinoma: Report of a case and review of literature. World J Gastrointest Pathophysiol 2011; 2(2): 26-30 [PMID: 21607163 DOI: 10.4291/wjgp.v2.i2.26] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
74 Rossi RE, Massironi S, Spampatti MP, Conte D, Ciafardini C, Cavalcoli F, Peracchi M. Treatment of liver metastases in patients with digestive neuroendocrine tumors. J Gastrointest Surg. 2012;16:1981-1992. [PMID: 22829240 DOI: 10.1007/s11605-012-1951-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
75 Fendrich V, Waldmann J, Bartsch DK, Langer P. Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol 2009;6:419-28. [DOI: 10.1038/nrclinonc.2009.82] [Cited by in Crossref: 81] [Cited by in F6Publishing: 62] [Article Influence: 6.2] [Reference Citation Analysis]